Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Articles by Baillargeon, J. Articles by Greifinger, R. B. PubMed Citation Articles by Baillargeon, J. Articles by Greifinger, R. B. Dual Diagnosis Patients Bipolar Disorder Mentally Ill Offenders Depression Addictive Disorders (General) Schizophrenia Spectrum Disorders

Parole Revocation Among Prison Inmates With Psychiatric and Substance Use Disorders

Dr. Baillargeon and Dr. Harzke are with the Department of Preventive Medicine and Ms. Baillargeon is with the Department of Correctional Managed Care, Community Health, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555 (e-mail: jbaillar{at}utmb.edu). Dr. Williams is with the Department of Medicine, University of California, San Francisco. Dr. Mellow is with the Department of Law, Police, Science, and Criminal Justice and Dr. Greifinger is with the Center for Research and Evaluation, John Jay College, City University of New York, New York City. Dr. Hoge is in private practice, New York City.

OBJECTIVE: This retrospective cohort study examined the association between co-occurring serious mental illness and substance use disorders and parole revocation among inmates from the Texas Department of Criminal Justice, the nation's largest state prison system. METHODS: The study population included all 8,149 inmates who were released under parole supervision between September 1, 2006, and November 31, 2006. An electronic database was used to identify inmates whose parole was revoked within 12 months of their release. The independent risk of parole revocation attributable to psychiatric disorders, substance use disorders, and other covariates was assessed with logistic regression analysis. RESULTS: Parolees with a dual diagnosis of a major psychiatric disorder (major depressive disorder, bipolar disorder, schizophrenia, or other psychotic disorder) and a substance use disorder had a substantially increased risk of having their parole revoked because of either a technical violation (adjusted odds ratio [OR]=1.7, 95% confidence interval [CI]=1.4–2.4) or commission of a new criminal offense (OR=2.8, 95% CI=1.7–4.5) in the 12 months after their release. However, parolees with a diagnosis of either a major psychiatric disorder alone or a substance use disorder alone demonstrated no such increased risk. CONCLUSIONS: These findings highlight the need for future investigations of specific social, behavioral, and other factors that underlie higher rates of parole revocation among individuals with co-occurring serious mental illness and substance use disorders.

Get information about faster international access.

Privacy Policy

Copyright © 2009 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us